These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6694970)

  • 41. Omeprazole: effects on oxidative drug metabolism.
    Henry DA; Somerville KW; Kitchingman G; Langman MJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):195-200. PubMed ID: 6487457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diurnal rhythms of aminopyrine metabolism: failure to sleep deprivation to affect them.
    Poley GE; Shively CA; Vesell ES
    Clin Pharmacol Ther; 1978 Dec; 24(6):726-32. PubMed ID: 568534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disposition of hexobarbital in the rat. Estimation of "first-pass" elimination and influence of ether anesthesia.
    Vermeulen NP; Danhof M; Setiawan I; Breimer DD
    J Pharmacol Exp Ther; 1983 Jul; 226(1):201-5. PubMed ID: 6864540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between the metabolism of hexobarbital and aminopyrine in vivo in rats.
    van der Graaff M; Vermeulen NP; Heij P; de Bree H; Breimer DD
    Xenobiotica; 1986 Dec; 16(12):1091-6. PubMed ID: 3798956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ether inhibition of ethanol metabolism in isolated rat liver parenchymal cells.
    Aune H; Stowell AR; Mørland J
    Alcohol Clin Exp Res; 1981; 5(4):550-5. PubMed ID: 7030112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-dependent kinetics of aminopyrine metabolism in the rat caused by product inhibition and determined by capillary GLC.
    Bast A; Scheefhals LW; Noordhoek J
    Pharmacology; 1982; 25(3):130-7. PubMed ID: 7146081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration.
    Muhoberac BB; Hanew T; Halter S; Schenker S
    Biochem Pharmacol; 1989 Nov; 38(22):4103-13. PubMed ID: 2512932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental hepatobiliary injury. Comparison of in vivo drug elimination with in vitro drug-metabolizing enzyme capacity in the rat.
    Willson RA; Hart FE; Hew JT
    Dig Dis Sci; 1981 Jan; 26(1):50-9. PubMed ID: 6780282
    [No Abstract]   [Full Text] [Related]  

  • 49. Lack of interference by sorbitol with aminopyrine breath test.
    Ramin VC; Bircher J
    Eur J Clin Pharmacol; 1990; 38(1):87-9. PubMed ID: 2109699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of glutathione depletion on aminopyrine and formaldehyde metabolism.
    Bhatt HS; Lober SB; Combes B
    Biochem Pharmacol; 1988 Apr; 37(8):1581-9. PubMed ID: 3358787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aminopyrine demethylation measured by breath analysis in cirrhosis.
    Bircher J; Küpfer A; Gikalov I; Preisig R
    Clin Pharmacol Ther; 1976 Oct; 20(4):484-92. PubMed ID: 975720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma levels of parent drug and metabolites in the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Harder M; Egberts EH
    Eur J Clin Pharmacol; 1982; 21(6):521-8. PubMed ID: 6804246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbits.
    Harris NL; Brenner DE; Anthony LB; Collins JC; Halter S; Hande KR
    Cancer Chemother Pharmacol; 1988; 21(4):323-8. PubMed ID: 3370741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
    Hepner GW; Vesell ES; Lipton A; Harvey HA; Wilkinson GR; Schenker S
    J Lab Clin Med; 1977 Sep; 90(3):440-56. PubMed ID: 894100
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of hepatic demethylation of aminopyrine by oral contraceptive steroids in humans.
    Herz R; Koelz HR; Haemmerli UP; Benes I; Blum AL
    Eur J Clin Invest; 1978 Feb; 8(1):27-30. PubMed ID: 417927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced synthesis of hepatic and plasma proteins in rats during diethyl ether anaesthesia.
    Bessesen A; Smith-Kielland A; Gadeholt G; Mørland J
    Acta Pharmacol Toxicol (Copenh); 1984 Apr; 54(4):241-6. PubMed ID: 6730981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of phenobarbitone pretreatment on disposition of amidopyrine and its metabolites in rat.
    Lockwood GF; Houston JB
    J Pharm Pharmacol; 1980 Sep; 32(9):619-23. PubMed ID: 6107362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.
    Hepner GW; Vesell ES
    N Engl J Med; 1974 Dec; 291(26):1384-8. PubMed ID: 4427643
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibition of hepatic drug metabolism by norethindrone.
    Field B; Lu C; Hepner GW
    Clin Pharmacol Ther; 1979 Feb; 25(2):196-8. PubMed ID: 759072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The aminopyrine respiratory test under the acute effect of ethanol. Evaluation of a new method for the measurement of microsomal functions of the liver].
    Audétat V; Preisig R; Bircher J
    Schweiz Med Wochenschr; 1977 Feb; 107(7):231-5. PubMed ID: 836561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.